{"id":13586,"date":"2023-07-11T09:00:45","date_gmt":"2023-07-11T09:00:45","guid":{"rendered":"https:\/\/dev.haugpartners.com\/?post_type=article&#038;p=13586"},"modified":"2024-09-26T09:05:40","modified_gmt":"2024-09-26T09:05:40","slug":"preliminary-means-preliminary-federal-circuit-emphasizes-the-non-binding-nature-of-the-ptabs-preliminary-guidance-under-the-pilot-program-for-motions-to-amend-in-medytox-inc-v-galderma-s","status":"publish","type":"article","link":"https:\/\/haugpartners.com\/article\/preliminary-means-preliminary-federal-circuit-emphasizes-the-non-binding-nature-of-the-ptabs-preliminary-guidance-under-the-pilot-program-for-motions-to-amend-in-medytox-inc-v-galderma-s\/","title":{"rendered":"Preliminary Means Preliminary: Federal Circuit Emphasizes the Non-binding Nature of the PTAB\u2019s Preliminary Guidance Under the Pilot Program for Motions to Amend in <i>Medytox, Inc. v. Galderma S.A.<\/i>"},"featured_media":0,"template":"","categories":[98,101],"acf":[],"_links":{"self":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article\/13586"}],"collection":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/types\/article"}],"wp:attachment":[{"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/media?parent=13586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haugpartners.com\/wp-json\/wp\/v2\/categories?post=13586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}